FundedIQ
Artificial Intelligence

Prenaital

Prenaital is an AI-driven healthcare company, to revolutionizing maternal care by improving detection & management of high-risk pregnancies.

prenaital.com Copenhagen, Denmark 1-10 employees
Total raised
$1.6M
Rounds
1
Latest
Seed
Sep 2025

Prenaital is an AI-driven healthcare company, to revolutionizing maternal care by improving detection & management of high-risk pregnancies.

Prenaital has raised $1.6M across 1 round. Its most recent round was a Seed of $1.6M in Sep 2025. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Sep 12, 2025
Seed
$1.6M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Prenaital is featured in

Similar companies

La Fraise

LaFraise develops artificial intelligence agents specifically for dentists to automate administrative processes.

Seed $3.7M
Flyway Health

Flyway Health is a healthtech company that offers brand-tailored AI agents for healthcare assistance.

Seed $4.0M
OrahVision

OrahVision offers AI driven technology that allows people with low vision to read and interact with books, documents, and text naturally.

Pre-Seed $20k
Yuanhe Vision

Yuanhe Vision is a high-tech enterprise specializing in AI-assisted ophthalmic diagnosis and optometry technology.

Series A $4.2M
Monsana

Monsana offers an AI-powered platform that connects eligible participants to relevant clinical trials throughout Europe.

Pre-Seed $590k
The Hub

The Hub is a recruitment platform for Nordic startups that offers career opportunities for global talents.

Series Unknown $1.0M
Curasight A/S

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications. The Company has developed a highly specific PET (Positron emission tomography) imaging ligand, uTRACE®, targeting the receptor uPAR, which is a biomarker only expressed in cancer. uTRACE® will become a game-changer in the diagnosis and treatment of cancer patients. In addition, with the promising results obtained within diagnostics Curasight will also pursues uPAR targeted radionuclide therapy using the uTREAT® ligand. As PET imaging and radionuclide therapy is based on the same uPAR binding peptide, a uTRACE® scan can precisely predict where subsequent targeted radiation therapy will be delivered. uTRACE® covers the diagnostic path and uTREAT® covers the therapy. This will be the new management and treatment of cancer patients in the future.

Series Unknown $3.1M
Acodyne

Acodyne is made for delivering cargo in difficult-to-reach locations for both military and commercial uses. Middle-mile logistics is being revolutionized globally by Acodyne's creation of the quickest unmanned eVTOL aircraft for large payloads.

Pre-Seed $2.9M
TechBBQ

TechBBQ is a non-profit event management organization that hosts startup capital programs.

Series Unknown $610k
Kvasir Technologies

Kvasir Technologies is a firm that has created a game-changing method to manufacture environmentally acceptable fuel for difficult-to-abate industries.

Series A $11.5M
Franklin Technologies

Franklin Technologies is a fintech company that provides e-commerce finance, payment cards, and automated accounting solutions.

Seed $1.8M
Festina Lente

Festina Lente is a company that specializes in providing knowledge-based solutions. Our focus is on developing advisory systems that provide individuals with a comprehensive understanding of their finances.

Series Unknown $28.8M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.